In November 2019, Advent International had acquired a 74 percent stake in Bharat Serums from its erstwhile private equity investors Orbimed Asia and Kotak PE, as well as the promoters of the company, the Daftary family, for around $500 million. Later, the PE fund acquired the family's remaining 26% stake.